Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr17.30 SEK
Change Today +0.40 / 2.37%
Volume 112.6K
BIOT On Other Exchanges
Symbol
Exchange
BIOT is not on other exchanges.
As of 11:29 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

biotage ab (BIOT) Snapshot

Open
kr17.00
Previous Close
kr16.90
Day High
kr17.30
Day Low
kr16.60
52 Week High
04/27/15 - kr17.30
52 Week Low
08/7/14 - kr9.80
Market Cap
1.1B
Average Volume 10 Days
41.1K
EPS TTM
kr0.79
Shares Outstanding
64.7M
EX-Date
04/29/15
P/E TM
21.9x
Dividend
kr0.75
Dividend Yield
3.47%
Current Stock Chart for BIOTAGE AB (BIOT)

Related News

No related news articles were found.

biotage ab (BIOT) Related Businessweek News

No Related Businessweek News Found

biotage ab (BIOT) Details

Biotage AB provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, and peptide synthesis, as well as separation and purification in the United States, Europe, and Japan. It offers systems and related consumables for evaporation, flash purification, microwave synthesis, peptide synthesis and purification, sample preparation, work-up tools, and process development solutions in organic chemistry and analytical chemistry areas. The company also offers contract-research services, as well as develops and produces polymer based materials. Biotage AB sells its products to pharmaceutical and biotech companies, contract research organizations and contract manufacturing organizations, academic institutions, and food producers. The company is headquartered in Uppsala, Sweden.

292 Employees
Last Reported Date: 08/14/14

biotage ab (BIOT) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: kr2.9M
Compensation as of Fiscal Year 2013.

biotage ab (BIOT) Key Developments

Biotage AB Proposes Dividend, Payable on May 06, 2015

The board of directors of Biotage AB announced annual general meeting to be held on April 28, 2015 to approve a proposal of dividend of SEK 0.75 per share. Record date for dividend is proposed to be April 30, 2015. Payment of dividend is estimated to be effectuated by Euroclear Sweden AB on May 06, 2015.

Biotage AB Reports Unaudited Consolidated and Parent Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Biotage AB reported unaudited consolidated and parent earnings results for the fourth quarter and full year ended December 31, 2014. Group net sales in the quarter were SEK 137.7 million, compared to SEK 121.6 million a year ago. Operating profit amounted to SEK 13.7 million against SEK 13.4 million reported last year. Profit before income tax was SEK 17.5 million against SEK 16.5 million reported last year. Net profit attributable to parent company's shareholders was SEK 16.6 million or SEK 0.26 per diluted share against SEK 18.5 million or SEK 0.28 per diluted share reported last year. Cash flow from operating activities amounted to SEK 28.99 million against SEK 21.1 million reported last year. Acquisition of property, plant and equipment was SEK 2.64 million against SEK 0.5 million reported last year. Acquisition of intangible assets was SEK 5.108 million against SEK 8.885 million reported last year. Group net sales were SEK 490.4 million, compared to SEK 444.6 million reported in the same period last year. Operating profit amounted to SEK 49.3 million against SEK 39.2 million reported last year. Profit before income tax was SEK 54.9 million against SEK 40.4 million reported last year. Net profit attributable to parent company's shareholders was SEK 51.1 million or SEK 0.79 per diluted share against SEK 41.4 million or SEK 0.61 per diluted share reported last year. Cash flow from operating activities amounted to SEK 80.9 million against SEK 56.8 million reported last year. Acquisition of property, plant and equipment was SEK 8.8 million against SEK 8.8 million reported last year. Acquisition of intangible assets was SEK 23.4 million against SEK 32.5 million reported last year. For the quarter, the parent company reported net sales of SEK 0.643 million against SEK 0.6 million reported in the same period last year. Operating profit amounted to SEK 8.4 million against operating loss SEK 3.2 million reported last year. Profit before income tax was SEK 75.8 million against SEK 145.0 million reported last year. Total profit for the period was SEK 75.4 million against SEK 148.2 million reported last year. For the year, the parent company reported net sales of SEK 2.5 million against SEK 2.4 million reported in the same period last year. Operating loss amounted to SEK 5.1 million against SEK 16.6 million reported last year. Profit before income tax was SEK 47.13 million against SEK 178.6 million reported last year. Total profit for the period was SEK 46.99 million against SEK 181.8 million reported last year.

Biotage AB Reports Consolidated and Parent Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Biotage AB reported consolidated and parent earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, on consolidated basis, the company reported net sales of SEK 118,525,000 against SEK 103,418,000 a year ago. Operating profit was SEK 12,591,000 against SEK 7,610,000 a year ago. Profit before income tax was SEK 11,727,000 against SEK 7,179,000 a year ago. Total profit attributable to parent company’s shareholders was SEK 10,998,000 or SEK 0.17 per share after dilution against SEK 6,919,000 or SEK 0.10 per share after dilution a year ago. Cash flow from operating activities was SEK 16,489,000 against SEK 14,164,000 a year ago. Acquisition of intangible assets was SEK 5,341,000 against SEK 6,743,000 a year ago. Acquisition of property, plant and equipment was SEK 1,354,000 against SEK 4,467,000 a year ago. For the nine months, on consolidated basis, the company reported net sales of SEK 352,625,000 against SEK 322,996,000 a year ago. Operating profit was SEK 35,604,000 against SEK 25,753,000 a year ago. Profit before income tax was SEK 37,575,000 against SEK 23,868,000 a year ago. Total profit attributable to parent company’s shareholders was SEK 22,906,000 or SEK 0.53 per share after dilution against SEK 22,906,000 or SEK 0.34 per share after dilution a year ago. Cash flow from operating activities was SEK 51,914,000 against SEK 36,404,000 a year ago. Acquisition of intangible assets was SEK 18,302,000 against SEK 23,628,000 a year ago. Acquisition of property, plant and equipment was SEK 6,131,000 against SEK 8,362,000 a year ago. For the quarter, on parent basis, the company reported net sales of SEK 634,000 against SEK 601,000 a year ago. Operating loss was SEK 4,456,000 against SEK 4,435,000 a year ago. Loss before income tax was SEK 22,033,000 against SEK 2,701,000 a year ago. Total loss was SEK 22,033,000 against SEK 2,701,000 a year ago. For the nine months, on parent basis, the company reported net sales of SEK 1,859,000 against SEK 1,798,000 a year ago. Operating loss was SEK 13,468,000 against SEK 13,450,000 a year ago. Loss before income tax was SEK 28,663,000 against profit of SEK 33,628,000 a year ago. Total loss was SEK 28,663,000 against profit of SEK 33,628,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOT:SS kr17.30 SEK +0.40

BIOT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOT.
View Industry Companies
 

Industry Analysis

BIOT

Industry Average

Valuation BIOT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTAGE AB, please visit www.biotage.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.